Literature DB >> 22064658

Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation.

Andrew E Vaughan1, Christine L Halbert, Sarah K Wootton, A Dusty Miller.   

Abstract

JSRV, a simple beta-retrovirus, is the etiologic agent of ovine pulmonary adenocarcinoma, a form of non-small cell lung cancer in sheep and goats. It has been shown that the envelope protein alone is sufficient to induce tumorigenesis in the lungs of mice when delivered via an adeno-associated viral vector. Here, we tested the hypothesis that JSRV envelope-induced tumors are maintained by a small population of tumor-initiating cells, termed cancer stem cells. To test this hypothesis, dissociated cancer cells were sorted from envelope-induced tumors in mouse lung based on the putative stem cell markers Sca-1, CD34, and CD133, the pluripotency-associated transcription factor Oct4, and the level of Wnt signaling. No association with increased tumor-initiating capacity was found with any of the cell-surface markers. In addition, we were unable to detect any evidence of Oct4 expression in tumor-bearing mouse lung. However, tumor cells possessing an active Wnt signaling pathway did show a significant correlation with increased tumor formation upon transplantation. Limiting dilution transplant analysis suggests the existence of a large fraction of cells with the ability to propagate tumor growth, with increasing tumor initiation potential correlating with activated Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064658     DOI: 10.1158/1541-7786.MCR-11-0285

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

Review 1.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23

Review 2.  WNT signaling - lung cancer is no exception.

Authors:  Judit Rapp; Luca Jaromi; Krisztian Kvell; Gyorgy Miskei; Judit E Pongracz
Journal:  Respir Res       Date:  2017-09-05

3.  Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer.

Authors:  Paola Cruz-Tapias; Vlada Zakharova; Oscar M Perez-Fernandez; William Mantilla; Sandra RamÍRez-Clavijo; Slimane Ait-Si-Ali
Journal:  Cancers (Basel)       Date:  2019-08-08       Impact factor: 6.639

4.  Transcriptional Response of Ovine Lung to Infection with Jaagsiekte Sheep Retrovirus.

Authors:  Anna Eleonora Karagianni; Deepali Vasoya; Jeanie Finlayson; Henny M Martineau; Ann R Wood; Chris Cousens; Mark P Dagleish; Mick Watson; David J Griffiths
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

5.  Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.

Authors:  You Zhou; Xiao Zheng; Bin Xu; Haifeng Deng; Lujun Chen; Jingting Jiang
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

6.  Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.

Authors:  Nicolle M Linnerth-Petrik; Lisa A Santry; Darrick L Yu; Sarah K Wootton
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer.

Authors:  Niu Zequn; Zhang Xuemei; Li Wei; Ming Zongjuan; Zhong Yujie; Hou Yanli; Zhang Yuping; Meng Xia; Wang Wei; Deng Wenjing; Fan Na; Yang Shuanying
Journal:  Oncotarget       Date:  2016-04-05

8.  Effect of Exogenous Transcription Factors Integration Sites on Safety and Pluripotency of Induced Pluripotent Stem Cells.

Authors:  S Yin; W Li; G Yang; Y Cheng; Q Yi; S Fan; Q Ma; F Zeng
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.